Manufacturing and Analytical Services
Top 5 Ways Integrated Drug Development Solutions Save You Time and Money
Since 2004, the average cost of bringing a new drug to market has increased from $800 million to about $2.6 billion, without, for the most part, shorter development time
ISSUE NO. 33 — End-to-End CNS Drug Development Solutions
Case Study―Evaluating Milling Conditions for Scaling Up a Nanosuspension Drug Product
Ophthalmic End-to-End Drug Development Solutions
Six Reasons to Choose Altasciences as Your CDMO Partner
Whether you are embarking on Preclinical safety testing, Phase I clinical trials, or need manufacturing services f
ISSUE NO. 28 — Applications of Liquid-Filled Hard-Shell Capsules in Drug Development
Case Study―Product Manufacturing and Analytical Testing for an Ocular Client
ISSUE NO. 27 — The Complexities of Early-Phase Ophthalmic Drug Development
Test Your Knowledge of Liquid-Filled Capsules
Thanks to updated screening methods and bioavailability enhancements, poorly soluble molecules comprise 70% to 80% of the small molecule products entering the drug development pipeline today. Since poorly soluble drugs are difficult to formulate as tablets, formulation scientists are looking to two-piece, liquid-filled hard-shell capsules as a solution.
Rapid Development of a Liquid-filled, Hard-Shell Capsule Formulation of Cannabidiol